141 related articles for article (PubMed ID: 28223942)
21. Ameloblastin and enamelin prevent osteoclast formation by suppressing RANKL expression via MAPK signaling pathway.
Chaweewannakorn W; Ariyoshi W; Okinaga T; Morikawa K; Saeki K; Maki K; Nishihara T
Biochem Biophys Res Commun; 2017 Apr; 485(3):621-626. PubMed ID: 28161637
[TBL] [Abstract][Full Text] [Related]
22. Characterization of AMBN I and II Isoforms and Study of Their Ca
Vetyskova V; Zouharova M; Bednarova L; Vaněk O; Sázelová P; Kašička V; Vymetal J; Srp J; Rumlová M; Charnavets T; Postulkova K; Reseland JE; Bousova K; Vondrasek J
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291486
[TBL] [Abstract][Full Text] [Related]
23. Bioinformatic analysis and molecular modelling of human ameloblastin suggest a two-domain intrinsically unstructured calcium-binding protein.
Vymetal J; Slabý I; Spahr A; Vondrásek J; Lyngstadaas SP
Eur J Oral Sci; 2008 Apr; 116(2):124-34. PubMed ID: 18353005
[TBL] [Abstract][Full Text] [Related]
24. Ameloblastin as a putative marker of specific bone compartments.
Jacques J; Hotton D; Asselin A; De la Dure-Molla M; Coudert AE; Isaac J; Berdal A
Connect Tissue Res; 2014 Aug; 55 Suppl 1():117-20. PubMed ID: 25158194
[TBL] [Abstract][Full Text] [Related]
25. Ameloblastin regulates cell attachment and proliferation through RhoA and p27.
Zhang Y; Zhang X; Lu X; Atsawasuwan P; Luan X
Eur J Oral Sci; 2011 Dec; 119 Suppl 1(Suppl 1):280-5. PubMed ID: 22243257
[TBL] [Abstract][Full Text] [Related]
26. Ameloblastin peptide encoded by exon 5 interacts with amelogenin N-terminus.
Su J; Chandrababu KB; Moradian-Oldak J
Biochem Biophys Rep; 2016 Sep; 7():26-32. PubMed ID: 27725968
[TBL] [Abstract][Full Text] [Related]
27. Splicing determines the glycosylation state of ameloblastin.
Kobayashi K; Yamakoshi Y; Hu JC; Gomi K; Arai T; Fukae M; Krebsbach PH; Simmer JP
J Dent Res; 2007 Oct; 86(10):962-7. PubMed ID: 17890672
[TBL] [Abstract][Full Text] [Related]
28. Evolutionary analysis of selective constraints identifies ameloblastin (AMBN) as a potential candidate for amelogenesis imperfecta.
Delsuc F; Gasse B; Sire JY
BMC Evol Biol; 2015 Jul; 15():148. PubMed ID: 26223266
[TBL] [Abstract][Full Text] [Related]
29. Extracellular matrix stiffness controls osteogenic differentiation of mesenchymal stem cells mediated by integrin α5.
Sun M; Chi G; Xu J; Tan Y; Xu J; Lv S; Xu Z; Xia Y; Li L; Li Y
Stem Cell Res Ther; 2018 Mar; 9(1):52. PubMed ID: 29490668
[TBL] [Abstract][Full Text] [Related]
30. Human ameloblastin gene: genomic organization and mutation analysis in amelogenesis imperfecta patients.
Mårdh CK; Bäckman B; Simmons D; Golovleva I; Gu TT; Holmgren G; MacDougall M; Forsman-Semb K
Eur J Oral Sci; 2001 Feb; 109(1):8-13. PubMed ID: 11330937
[TBL] [Abstract][Full Text] [Related]
31. Ameloblastin gene (AMBN) maps within the critical region for autosomal dominant amelogenesis imperfecta at chromosome 4q21.
MacDougall M; DuPont BR; Simmons D; Reus B; Krebsbach P; Kärrman C; Holmgren G; Leach RJ; Forsman K
Genomics; 1997 Apr; 41(1):115-8. PubMed ID: 9126491
[TBL] [Abstract][Full Text] [Related]
32. Laminin-5 activates extracellular matrix production and osteogenic gene focusing in human mesenchymal stem cells.
Klees RF; Salasznyk RM; Vandenberg S; Bennett K; Plopper GE
Matrix Biol; 2007 Mar; 26(2):106-14. PubMed ID: 17137774
[TBL] [Abstract][Full Text] [Related]
33. Activation of FAK is necessary for the osteogenic differentiation of human mesenchymal stem cells on laminin-5.
Salasznyk RM; Klees RF; Boskey A; Plopper GE
J Cell Biochem; 2007 Feb; 100(2):499-514. PubMed ID: 16927379
[TBL] [Abstract][Full Text] [Related]
34. Ameloblastin induces tumor suppressive phenotype and enhances chemosensitivity to doxorubicin via Src-Stat3 inactivation in osteosarcoma.
Ando T; Kudo Y; Iizuka S; Tsunematsu T; Umehara H; Shrestha M; Matsuo T; Kubo T; Shimose S; Arihiro K; Ogawa I; Ochi M; Takata T
Sci Rep; 2017 Jan; 7():40187. PubMed ID: 28054649
[TBL] [Abstract][Full Text] [Related]
35. Focal adhesion kinase signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells.
Salasznyk RM; Klees RF; Williams WA; Boskey A; Plopper GE
Exp Cell Res; 2007 Jan; 313(1):22-37. PubMed ID: 17081517
[TBL] [Abstract][Full Text] [Related]
36. Effect of enamel matrix derivative and of proline-rich synthetic peptides on the differentiation of human mesenchymal stem cells toward the osteogenic lineage.
Ramis JM; Rubert M; Vondrasek J; Gayà A; Lyngstadaas SP; Monjo M
Tissue Eng Part A; 2012 Jun; 18(11-12):1253-63. PubMed ID: 22429009
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of SLC41A1 magnesium transporter promotes mineralization and attenuates magnesium inhibition during osteogenesis of mesenchymal stromal cells.
Tsao YT; Shih YY; Liu YA; Liu YS; Lee OK
Stem Cell Res Ther; 2017 Feb; 8(1):39. PubMed ID: 28222767
[TBL] [Abstract][Full Text] [Related]
38. Coemergence of the Amphipathic Helix on Ameloblastin With Mammalian Prismatic Enamel.
Su J; Bapat RA; Visakan G; Moradian-Oldak J
Mol Biol Evol; 2022 Nov; 39(11):. PubMed ID: 36161489
[TBL] [Abstract][Full Text] [Related]
39. Sulfated hyaluronan/collagen I matrices enhance the osteogenic differentiation of human mesenchymal stromal cells in vitro even in the absence of dexamethasone.
Hempel U; Möller S; Noack C; Hintze V; Scharnweber D; Schnabelrauch M; Dieter P
Acta Biomater; 2012 Nov; 8(11):4064-72. PubMed ID: 22771456
[TBL] [Abstract][Full Text] [Related]
40. A novel collagen-binding peptide promotes osteogenic differentiation via Ca2+/calmodulin-dependent protein kinase II/ERK/AP-1 signaling pathway in human bone marrow-derived mesenchymal stem cells.
Shin MK; Kim MK; Bae YS; Jo I; Lee SJ; Chung CP; Park YJ; Min do S
Cell Signal; 2008 Apr; 20(4):613-24. PubMed ID: 18248957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
